Stocks / NASDAQ / bioAffinity Technologies Inc.

bioAffinity Technologies Inc.

Our Opinion

bioAffinity Technologies Inc. is on the Cruelty-Free Investing usage of animals list because they undertake pre-clinical studies on animals to examine the safety profile of their medications.

Supporting Evidence:

The company stated in the following press release that they use animals for product testing.

“We intend to license our therapeutic products for clinical development should animal and pre-clinical studies prove successful.” Read the following article

Company Description

bioAffinity Technologies, Inc. operates as a biotechnology company. The Company develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. bioAffinity Technologies serves customers in the United States.

Company Website: